Key result
Transradial access for preprocedural coronary angiography was associated with fewer 30-day mortality and major vascular complications after TAVR than transfemoral access (3.3% vs 6.3%, p=0.04).
Why the study?
Vascular injury and bleeding complications remain frequent after TAVR, and whether the access site of preprocedural coronary angiography affects TAVR-related complications is not known.
Does transradial access for preprocedural coronary angiography reduce 30-day mortality and major vascular complications in patients undergoing subsequent TAVR?
Cohort (n=1,002)
Does transradial access for preprocedural coronary angiography reduce 30-day mortality and major vascular complications in patients undergoing subsequent TAVR?
Absolute Event Rate: 3.3% vs 6.3%
p-value: p=0.04
Transradial access for preprocedural coronary angiography before TAVR is associated with significantly lower rates of subsequent TAVR-related vascular complications compared to transfemoral access.
TRA for pre-TAVR CAG was associated with fewer vascular complications; leaves open whether randomized data would confirm benefit.
Background: Vascular injury and bleeding complications remain frequent after transcatheter aortic valve replacement (TAVR). Whether the access-site of preprocedural coronary angiography (CAG) affects TAVR-related complications is not known. The aim of this study was to evaluate the impact of transradial (TRA) versus transfemoral access (TFA) for preprocedural CAG on outcomes in patients undergoing subsequent TAVR. Methods: The study cohort included 1002 patients undergoing transfemoral TAVR, of whom 39.4% (395/1002) had undergone radial and 60.6% (607/1002) femoral access for pre-TAVR CAG. The primary endpoint was a composite of 30-day mortality and major vascular complications after TAVR. Key secondary endpoints included VARC-3-defined complications. Results: The primary endpoint occurred less frequently in patients with prior TRA (3.3%) as compared to patients with prior TFA (6.3%, p = 0.04), which was mainly driven by significantly lower rates of major vascular complications (0.8% vs 2.5%, p = 0.05). Moreover, incidences of periprocedural access-related vascular injury and unplanned endovascular interventions were lower in TRA patients (13.2% vs 18.0%, p = 0.05). The rate of major bleeding tended to be lower in the TRA (1.5%) as compared to the TFA group (3.5%) but was not significantly different (p = 0.07). Moreover, the rate of life-threatening bleeding was comparable between both groups (0.5% vs 0.8%, p = 0.71). Conclusion: Transradial access for preprocedural CAG was associated with significantly lower rates of vascular complications following subsequent TAVR as compared to transfemoral access. However, despite the tendency to lower major bleedings with transradial access, no significant association was detectable between the access-site of coronary angiography and TAVR-related bleeding complications.
No takes yet. Share an insight, caveat, or question.
Al‐Kassou et al. (2023) conducted a cohort in Transcatheter aortic valve replacement (TAVR) (n=1,002). Transradial access for preprocedural coronary angiography vs. Transfemoral access for preprocedural coronary angiography was evaluated on Composite of 30-day mortality and major vascular complications after TAVR (p=0.04). Transradial access for preprocedural coronary angiography was associated with fewer 30-day mortality and major vascular complications after TAVR than transfemoral access (3.3% vs 6.3%, p=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: